A conceptual paradigm for multiparametric optical biosensing in a lab-on-a-chip, using the cascaded transmission of light through a photonic crystal that contains microfluidic channels and is embedded in a glass slide, is demonstrated. Accurate detection of multiple disease-identifying biomarkers is facilitated by the interaction of surface and photonic-band-gap waveguide modes. Through finite-difference time-domain simulations, levels of light transmission through the device are shown to be simultaneously responsive to analyte bindings and layer thicknesses at different locations along a single optical transmission path through the photonic crystal. Our multiparametric biosensing mechanism supersedes traditional singleresonance-shift-based biosensing and provides a more detailed spectral fingerprint of various diseases or various stages of a given disease. Moreover, the spectral line shape due to the engineered optical modes can logically discriminate between different concentrations of several analytes flowing through the microfluidic channels. The simultaneous detection and differentiation of (combinations of) distinct analytes using a single measurement on one device offers a paradigm for optical biosensing.
I. INTRODUCTION
Lab-on-a-chip (LOC) optical biosensing offers a rapid and simple means for medical diagnostics. The ultimate goal is to detect and monitor early-stage disease markers from body tissue and fluid samples almost instantly and in situ by using a millimeter-to centimeter-scale optical chip-without recourse to time-consuming and expensive external laboratory testing. Such a biosensor is functionalized by the attachment of antibodies or DNA aptamers [1] to interior surfaces in different regions of the optical chip that can bind predetermined disease-identifying proteins or other biological molecules, leading to a detectable change in the optical-resonance characteristics of the chip. In this article, we demonstrate, by using a simplified paradigm, that many of the ultimate features of the LOC optical biosensor can be realized by using a thin-film, photonicband-gap (PBG) material containing microfluidic channels as the active region of the chip. The distinctive features include the realization of high sensitivity and a low limit of detection. Also, the PBG material provides a "clean slate" in which desired optical resonances are well separated in frequency from spurious resonances that can clutter the detected signal with unwanted noise. Most significantly, our proposed LOC uses extended optical modes that overlap a large volume of the fluid sample and provides detailed spectral fingerprints that can distinguish between different concentrations of multiple disease markers in a single measurement. This proposal offers considerably greater functionality than conventional biosensors studied previously.
Photonic crystals (PCs) [2, 3] are dielectric materials engineered with periodic variations of about half the wavelength of light. Most notably, certain PCs completely inhibit the propagation of light through them over a range of frequencies known as the photonic band gap (PBG). PBGs offer "blank slates" for engineering optical modes within defects surrounded by the bulk PC [4] . These defect modes concentrate light spatially within and near the defect regions. As light may not propagate through the PC material surrounding the defect due to the existence of the PBG, defect modes can confine light in either the high-or low-refractive-index regions of the optical microstructure. It is quite common for such states to exist in lines of altered unit cells in a PC, giving rise to a waveguide effect due to the associated line-defect modes. Surfaces truncating an infinite PC also give rise to guided surface modes [5] . The PBG provides an opportunity for optical sensing, in which high-quality-factor modes can have field energies concentrated in the low-refractive-index regions, where the analyte to be detected is likely to reside. PBGbased sensing thereby enables very high sensitivity without sacrificing a low limit of detection. The former property requires strong optical overlap of the electromagnetic field with the analyte, whereas the latter property traditionally requires a high quality factor of the field mode. These two properties are often in opposition in conventional biosensors that do not utilize a PBG.
In our biosensing mechanism, the weak coupling between an interior PBG waveguide and nearby surface modes provides a detailed spectral fingerprint of the presence of multiple analytes. This situation occurs not only from frequency shifts of optical resonances due to analyte binding, but as a result of other features of the spectral signature arising from changes in coupling between the optical-resonance modes. An important aspect of our biosensor is that it utilizes extended (guided) opticalresonance modes rather than point-localized modes [6] . Using a mousetrap analogy, this aspect makes it easier for the "mouse" (i.e., analyte) to find the "trap" (i.e., binding sites) by spreading it over a larger region, thereby reducing the time required for detection.
Mathematically, optical modes in a PC are described by Maxwell's wave equation [7] :
∇ × f∇ × ½ε −1 ðrÞ · H j;k ðrÞg ¼ ω j ðkÞ c 2 H j;k ðrÞ: ð1Þ
The magnetic-field eigenfunction H j;k ðrÞ of the wave equation (1) represents the spatial field distribution for the jth mode of the PC-corresponding to (angular) frequency ω j ðkÞ-at a given wave vector k. A similar, but slightly different, equation applies for the electric fields E j;k ðrÞ. In accordance with an orthogonality condition satisfied by these eigenfunctions, the fields for the lower-frequency modes tend to be confined to higher-refractive-index regions. For clarity, we refer to such modes as "skeleton modes" of the biosensor. The "skeleton" consists of a highindex solid, such as silicon, containing a periodic array of microfluidic channels. Accordingly, we refer to optical modes concentrated mainly in the lower-index modes as the "fluidic modes." In air-dielectric PCs, modes analogous to the foregoing are often referred to as the "dielectric modes" and the "air modes" [7] .
PC-based optical biosensors without a PBG are utilized by many researchers. Light concentration-in the region of the analyte to be detected-has been identified as vital for effective sensitivity. PC-based biosensors often incorporate defect structures [6, [8] [9] [10] due to their ability to concentrate light in regions where periodicity is broken. However, neither the interaction of multiple defect modes nor the use of a complete PBG to eliminate spurious optical modes has been fully explored.
Traditional biosensors are characterized by two key performance metrics: (i) Sensitivity is the change in output signal (e.g., transmission resonance frequency, transmission levels at resonance, etc.) resulting from an infinitesimal change in the analyte (e.g., binding thickness).
(ii) Limit of detection is the minimum amount of analyte variation required to detect an output signal change. In traditional biosensors that confine light by total internal reflection, these two metrics are usually opposed to each other. High sensitivity requires the optical field of a resonance to have a strong evanescent component in the lower-index region where the analyte resides.
Unfortunately, this strong evanescence is often accompanied by a lowering of the quality factor of the optical resonance [11] .
A number of optical biosensors are now commercially available. Many of these sensors employ surface plasmon resonance (SPR) [12] . Among the drawbacks of SPR sensors, the lossy nature of the metallic surface as well as the need for complicated light-coupling mechanismssuch as prisms-are the most notable. Numerous grating and waveguide-based sensors have also been previously proposed. Our design enhances the mechanism of waveguide biosensors [9] , grating-based sensors [13] , and grating-coupled waveguide sensors (e.g., optical waveguide light-mode sensors) [14] [15] [16] . We employ a dualgrating arrangement for light coupling into and out of a waveguide. In our design, both surface gratings, as well as the interior waveguide, offer analyte-binding sites, leading to multiparametric detection based on a single transmission spectrum measurement.
In a conventional biosensor detecting thin-layer analytes, the frequency shift of transmission or reflection resonances is the indicator of analyte binding. In a PC structure with multiple modes, we consider the mth mode of the PC-based biosensor to shift slightly in (angular) frequency from ω m to ω 0 m due to a "small" change δt in analyte binding, i.e., thickness changes from t to (t þ δt). The corresponding frequency change δω m ¼ ω 0 m − ω m defines the sensitivity S m of the mth mode of the system for resonance shifts (an additional transmission-level sensitivity is described later):
In Eq. (2), F m is a measure of the optical field concentration at the binding surface for the incremental analyte layer of thickness δt. A detailed prescription for calculating F m is given in Appendix A. We note here that the quantity F m has the dimension of inverse length and may be physically thought of as the optical field concentration per unit length of analyte increment around the analytebinding surface. Consequently, sensitivity has units of the frequency shift per unit of the analyte-thickness change. The limit of detection t ðlimÞ m of the mth spectral resonance is defined in terms of its quality factor Q m as
For the limit of detection defined by Eq. (3), the quantity η is a dimensionless number, of the order of unity, corresponding to the minimum resolvable separation between two adjacent resonance peaks in a spectrometer used for the biosensing task. As per the definition of F m [cf. Eq. (A3) in Appendix A], the limit of detection has the dimension of the analyte thickness.
While the traditional biosensing mechanism defined by the above metrics considers only individual resonance shifts, our proposed multiparametric biosensor also exploits the change in coupling between modes of a PC induced by different analyte bindings. This difference gives rise to changes in light-transmission peak levels-in addition to frequency shifts-in response to changes to analyte-layer thickness. This change provides a more detailed spectral fingerprint for multiple disease markers in a sample.
Some previous liquid-infiltrated PC biosensors rely upon refractive-index changes to the entire liquid fraction of the device [11, 17] . In contrast, our biosensor detects thin-layer analytes attached to designated binding sites in the PC. The former approach has very significant limitations. For example, in a sample of blood plasma, it is possible that different proportions of different protein components of the mixture can lead to the same value of refractive index for the fluid. In order to detect specific substances within a very mixed sample like blood plasma, it will be essential to isolate them. Our multiparametric PC biosensor detects analytes through binding (which can also be described as isolation or immobilization) based on biorecognition. The biorecognition occurs via the binding of complementary biological molecules, such as antibody-antigen binding, or DNA aptamer-protein binding [1, 18] . Recognition agents are placed at specific locations in the PC, where the arrival -and subsequent binding-of complementary disease markers alters optical resonances as well as couplings between optical modes.
Structurally, the repetitive geometry of the PC provides a convenient set of extended biorecognition sites spread over the many PC unit cells, allowing for a broad "net" to capture disease markers. Additionally, PCs can be designed in a variety of ways to admit large flow channels-both at the surface and within the interior of the chip. Fluid flow through PCs for the purpose of sensing is demonstrated in previous literature [19, 20] .
The PBG plays a pivotal role in our design, providing a blank slate for engineering the optical modes tailored specifically towards the biosensing task at hand. A complete omnidirectional PBG-as opposed to an incomplete stop gap-offers a greater robustness and signal-to-noise ratio for the sensor. Once the biosensing modes are generated to lie within the PBG, there is a sufficient free spectral range available for these modes to be "uncluttered" in frequency space due to the absence of other spurious modes accessible by improper beam collimation, disorder-induced scattering, or finite-size effects.
II. DESIGN OF SURFACE AND LINE-DEFECT MODES
We consider a two-dimensional (2D) PC LOC to illustrate our multiparametric biosensing paradigm. The square-lattice PC unit cell (Fig. 1) is formed by the immersion of a square dielectric block of refractive index n ¼ 3.4 (ε ¼ 11.56) in a fluid matrix of n ¼ 1.35 (ε ¼ 1.8225). The unit cell shown is an a × a square with a w × w square dielectric block at the center. We choose w=a ¼ 0.40 to optimize the 2D PBG of the PC for light with the electric field polarized out of the plane (i.e., in the z direction). The system has a complete PBG for 0.263 ≤ ðωaÞ=ð2πcÞ ≤ 0.326, i.e., an approximately 21.5% band gap to center frequency ratio.
The active region of our chip [ Fig. 2 (a)] starts with a 2 × ð2l þ 1Þ supercell, consisting of two unit cells in the x direction and (2l þ 1) unit cells in the y direction. We identify, below, the optimal value of l for our biosensing application. The chip is encased in glass (n ¼ 1.5, ε ¼ 2.25), forming a superstrate above and a substrate below it in the y direction. The structure is periodically repeated in the x direction.
We now modify the basic PC, such that the resulting chip admits a central waveguide mode and two surface modes, which can all be excited by an external plane wave impinging on the chip along the y direction, normal to its surface. We also require that the surface and waveguide modes are nearly in resonance with each other. Detailed geometric modifications are shown in Fig. 2(a) . Along the y center of the finite-thickness PC, we introduce a line defect consisting of smaller dielectric blocks of alternating side lengths w wg and (w wg þ δw wg ). This structure forms a single-mode waveguide. There are l unit cells of PC above and below this central line defect. In the dielectric blocks at the top and the bottom of the chip (adjacent to the glass superstrate-substrate structure), we increase the side length of alternate squares (in the x direction) to (w þ δw sg ). This structure serves as a grating coupler for incident and exiting light. In order to generate surface modes in the grating region, we extend the glass superstrate-substrate structure to encroach into the PC unit cells lying adjacent to them by a distance of (τ × a), where τ is the surface truncation parameter satisfying the requirement τ ∈ ½0; 1Þ [cf. Fig. 2(b) ]. It is important to note that not all values of τ ensure the existence of a surface mode for the grating coupler, and the choice of τ provides a limited range of freedom for tailoring these surface-mode frequencies. There are now (l − τ) unit cells of PC material above and below the central line-defect region. Our 2D model is a prototype for essential design principles and the multiparametric biosensing paradigm. In a real 3D LOC biosensor, the solid square regions of the 2D PC [ Fig. 2(a) ] can represent square-log cross sections of a 3D simplified woodpile PBG material [cf. Fig. 2(c) ]. These logs extend in the z direction and are separated by orthogonal logs extending in the x direction and periodically arrayed in the z direction. This 3D architecture is structurally stable and contains a connected network of microfluidic channels. In 3D, the line-defect mode becomes a planar guided mode. Our 2D model illustrates the design and biosensing principle of the realistic 3D LOC using a simplified geometry. In our simplified model, we assume a perfect antireflection coating at the exterior glass surface to air. We consider only TMpolarized light, for which the electric field lies along the z direction, perpendicular to the plane of the 2D PC.
Our LOC biosensor is designed to operate in optical transmission mode, whereby detailed spectral signatures of multiple disease markers are displayed through light transmitted from the substrate to the superstrate of the chip. This display requires a sequence of energy and momentum conservation steps for the incident photons.
External light coupling into surface modes requires specific design considerations. On a photonic band diagram, surface modes appear below the light line of the encasing superstrate-substrate structure [5] . To compensate for this, additional transverse momentum must be supplied (by a prism or surface grating) to photons incident externally to couple to the propagating surfacelocalized modes. A doubling of the spatial period of a structure by a surface grating halves the period in k-space of the band diagram, resulting in a band-folding effect, in which surface-mode bands are folded back onto the Γ point (k ¼ 0). This folding is achieved by a perturbation of δw sg to the dielectric blocks lying at the surface of the truncated PC [ Fig. 2(a) ]. The small period-doubling perturbation changes the mode frequencies very slightly but folds the surface-mode bands to lie above the light line, making them accessible by normally incident light [cf. Fig. 3(a) ].
Given the finite dwell time of incident photons in the surfaces and central waveguide (as defined by their respective quality factors), an exact frequency match between these modes is not required for a photon to evanescently couple from the surface to the central modes by tunneling through the PBG. Nevertheless, energy conservation requires that their frequency mismatch not be large compared to their individual resonance linewidths.
To fine-tune the central waveguide spectrum, a perioddoubling perturbation δw wg is also introduced into the waveguide line defect to alternating defect blocks [ Fig. 2(a) ]. This perturbation enables finer alignment of the surface and line-defect modes in the ω-k space than is possible by exploring changes to w wg alone. Details of the alignment of surface and line-defect modes at the Γ point on a band diagram are shown in Fig. 3(b) .
Band diagrams for the surface and line-defect modes are computed by using the plane-wave expansion method (PWEM), implemented by the freely available software MIT PHOTONIC BANDS [21] . For all PWEM calculations, a spatial resolution of 64 mesh points per unit cell is employed in each direction, resulting in the same number of plane waves being used to calculate the field distributions. A search over the geometric parameters τ, δw sg , w wg , and δw wg is performed to find suitable surface and linedefect-mode frequencies that are almost coincident at the Γ point (k ¼ 0) of the band diagram. As seen in Figs. 3(a) and 3(b), the doubly degenerate surface modes (the top and bottom surface modes are degenerate by mirror symmetry) are close but not exactly coincident with the linedefect mode at the Γ point. This small free spectral range between the surface and line-defect frequencies plays a vital role in the functionality of our biosensor. It allows for conventional frequency-shift biosensing by the surface and line-defect modes individually. More significantly, the analyte-binding-dependent frequency overlap between the resonance peaks related to surface and line-defect modes provides a variable fingerprint in both the spectral position and transmitted intensity for multiple disease markers. Fig. 3 (e), which also shows the L PWEM supercell used to calculate the modes. The approximate alignment at the Γ point of the surface and line-defect modes is seen in Fig. 3 (b). These modes, obtained from supercell band structure calculations, provide an interpretative tool for our finite-difference time-domain (FDTD) simulation results on the actual finite-size chip.
III. SIMULATION OF OPTICAL TRANSMISSION
FDTD simulations of total optical transmission through the PC chip are performed by using MEEP [22] . Normally incident plane waves illuminate the symmetric chip consisting of a central line defect separated by (l − 1) unit cells of PC from τ-truncated surfaces both above and below [cf. Fig. 2(a) , for which τ ¼ 0.50 and l ¼ 4]. The FDTD light source is embedded in the glass substrate below the chip. Bloch-periodic boundary conditions are imposed along the x boundaries and perfectly matched layer absorbers are placed at the y extremities of the geometry.
The results of FDTD simulation with various spatial resolutions are an indicator of the response of the biosensor to various degrees of fabrication imperfection (cf. Appendix C). That is to say, random structural variations in a real biosensor on scales smaller than our FDTD mesh spacing have a negligible effect on the predicted transmission spectral fingerprint. Two values are used for the spatial resolution of the FDTD calculations. Both 40 and 80 mesh points per lattice constant are implemented, and their results compared (with the majority of the discussion relegated to Appendix C). Analyte material is considered to have a refractive index n ¼ 1.45 (ε ¼ 2.1025). Four different analyte thicknesses are considered: t=a ∈ f0.025; 0.050; 0.075; 0.100g. These analyte-thickness increments correspond to a single mesh step for the simulation using 40 mesh points per lattice period.
Three primary sites are considered for analyte binding on the interior surfaces of the microfluidic chip, namely, the top and bottom surface gratings, as well as the waveguide line defect-represented in Fig. 4 by red, green, and blue outlines, respectively. We label these sites as W (for waveguide), T (for top surface grating), and B (for bottom surface grating). Various combinations of analyte binding, corresponding to three distinct disease markers, are studied, revealing a variety of different spectral signatures in transmission. In particular, a total of seven combinations of analyte binding are possible with binding in at least one of the three binding sites.
For simplicity, we ignore the thickness of the biorecognition layer and implicitly assume that it has a refractive index equal to that of the analyte. In our model, analyte binding simply enhances the thickness of the thin-film layer around the binding sites.
IV. SPECTRAL FINGERPRINTS OF ANALYTE BINDING A. Conventional resonance-shift biosensing
We begin by recapturing the behavior of a traditional optical biosensor based on individual surface or line-defect resonance modes using two simplified device designs. The first, referred to as the S chip, involves surface modes only. Here, we use the geometry shown in Fig. 2(a) with l ¼ 4 and choose (w wg ¼ w, δw wg ¼ 0) to eliminate the central waveguide completely. We retain δw sg =a ¼ 0.05 and τ ¼ 0.50, so that the structure admits surface modes. The second, referred to as the L chip, involves the central line-defect waveguide modes only. Here, we choose δw sg ¼ 0 and τ ¼ 0 to eliminate surface modes completely while retaining the waveguide line defect with w wg =a ¼ 0.25 and δw wg ¼ 0.10. The effects of analyte binding on the transmission spectrum for the S chip and the L chip are shown in Fig. 5 based on a spatial resolution of 80 mesh points per unit of periodicity for the FDTD calculations.
For the S chip [ Fig. 5(a) ], the total transmission coefficient is less than 2% for a thick (l ¼ 4) chip. With increments to the analyte-layer thickness around the surface-grating blocks, the weak transmission resonance shifts to lower frequencies. Clearly, the S chip acts like a conventional biosensor-with very weak transmission due to the long tunneling distance of photons through the PBG from the bottom to the top surface modes. The confined surface modes decay exponentially into the PC material, wherein the "tails" of their evanescent fields overlap, establishing a very weak coupling between two degenerate modes. However, the strength of the evanescent coupling is small compared to the resonance linewidth of each surface mode. As a result, only a single transmission peak can be resolved, despite the presence of two coupled resonances (cf. Appendix B).
The S-chip response indicates that a separation of seven unit cells of PC material between the surface gratings (l ¼ 4) almost completely eliminates coupling between them. As we show below, a much larger surface-mode transmission signal is achieved by the introduction of a central waveguide mode to mediate the coupling between the surface resonances.
For the L chip with l ¼ 4 [ Fig. 5(b) ], the signature of the central waveguide mode appears as a pronounced transmission peak that redshifts in response to analyte-thickness increments. The peaks are much sharper than those for the S chip due to the higher quality factor of the central waveguide embedded in the PBG. The addition of surface modes to the L chip makes this waveguide mode more accessible to incident light. As shown below, the waveguide transmission peak broadens when the surface modes are added. In the absence of surface modes, the L chip behaves like a traditional high-Q resonance-shift biosensor. The only improvement here is that, within a PBG, it is possible to concentrate more light in the low-refractive-index region of the sensor without sacrificing resonance quality factor. This concentration simultaneously enables high sensitivity and a low limit of detection.
B. Biosensing with coupled resonances
We now incorporate both the surface and the line-defect modes into a single design to obtain what we refer to as the LS chip [ Fig. 2(a) ]. This chip provides our paradigm for multiparametric biosensing, in which analyte binding not only shifts individual resonance frequencies but also alters the coupling strengths between resonance modes. Consequently, different analyte combinations reveal distinct spectral fingerprints in the optical transmission. We note here that the chip thickness plays a crucial role in engineering the coupling between the modes, the details of which are in Appendix C.
We turn our attention to the transmission spectrum results for the LS chip in Fig. 6 for the case of no analyte binding (t=a ¼ 0). The interaction of surface and In what follows, we focus on the LS chip with l ¼ 4, using FDTD spatial resolution of 80 mesh points per unit of periodicity. As noted in Appendix C, this value of l ¼ 4 is the optimal chip thickness for establishing a weak coupling between surface and line-defect modes of the LS chip. For the l ≥ 4 case, the coupling between the two unhybridized surface modes is sufficiently weak that there is a single SLM transmission peak (Fig. 6); i.e., the splitting in the two SLM frequencies calculated in Appendix B is small compared to the resonance linewidths. For l < 4, there are two distinguishable SLM peaks, as seen in Fig. 11(a) in Appendix C. From the discussion in Appendix C, we deduce that l ¼ 4 provides the optimal coupling level between the optical modes of the device for biosensing.
We distinguish different analyte-binding configurations by the labels W, T, and B, referring to the central waveguide, top surface grating, and bottom surface grating, respectively. Analyte-binding configurations involving more than one site are likewise labeled WT, WB, BT, and WBT. Transmission spectra calculated with various thicknesses of pure W binding are presented in Fig. 6 . In the plots shown, we proceed in analyte-thickness increments that amount to two mesh steps in our FDTD calculations, i.e., δt=a ¼ 0.025 ¼ 2=80. As seen from Fig. 6 , the spectral fingerprint of our device undergoes distinguishable changes as a result of these analyte-thickness increments. We demonstrate in Appendix C that our device is, in fact, capable of detecting analyte-thickness changes that are of the same order as the fabrication precision of the device. In Fig. 6 , the peak due to the WLM progressively redshifts with increments to the analyte thickness, as in a conventional biosensor. On the other hand, for the SLM, the peak transmission level increases with the thickness of W binding. This change of transmission levels in one mode, due to analyte binding near another mode, is an important feature of our biosensor.
W binding redshifts the (unhybridized) line-defect mode, which is manifested as a redshift of the WLM. The redshift of the line-defect mode enhances the coupling between the unhybridized surface modes, which enhances the tunneling of photons from one surface mode to the other via the central waveguide. The net result is a transmission-level enhancement at the SLM resonance, in addition to a redshift of the WLM resonance.
As discussed in Appendix B, a coupling strength of μ (with units of frequency squared) between two degenerate modes with frequency ω results in the new frequencies ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi ω 2 AE jμj p for the hybridized modes. For the case of the degenerate surface modes (unhybridized) with frequency ω S , it is shown in Appendix B that the SLMs attain frequencies of ω S and ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
, where κ is the coupling strength (with units of frequency squared) between the surface and line-defect modes and ω L is the unhybridized line-defect-mode frequency. The direct coupling between the top and bottom surface modes is negligible for the thick (l ¼ 4) chip.
The indirect coupling between surface modes within the LS chip of jμj ¼ jκj 2 =ðω 2 L − ω 2 S Þ is analogous to the quantum-mechanical expression of the second-order perturbation theory [23] . Photons in the bottom surface mode of frequency ω S can tunnel to the intermediate off-resonant waveguide mode of frequency ω L for a short time before tunneling again to the energy-conserving final state at the opposite surface. As the difference (ω 2 L − ω 2 S ) becomes smaller, the indirect effective coupling is enhanced, even with very little change to κ. Analyte binding at W causes ω L to redshift, bringing it closer to ω S , and thereby enhancing the indirect interaction between the upper and lower surface modes. This enhancement manifests in greater SLM transmission. Therefore, in our multimode biosensor, analyteinduced frequency shifts also modify the effective coupling between modes, resulting in transmission enhancement or suppression behavior.
We now discuss the transmission spectral fingerprints for all the different possible analyte-binding configurations in FIG. 6 . FDTD results for the analyte binding at the W site for l ¼ 4 of the LS chip. In addition to peak-shift biosensing by the WLM, the enhancement of the SLM transmission (due to enhanced indirect surface-mode coupling as a result of analyte binding) is a distinctive feature of our design. the LS chip. A synopsis of the four remaining analytebinding scenarios that result in distinctive spectral fingerprints is presented in Fig. 7 .
For BT analyte binding [ Fig. 7(a) ], the SLM transmission peak is redshifted as in a conventional surface-mode PC biosensor. The uniform analyte binding at B and T redshifts both of the unhybridized surface-mode frequencies equally. No appreciable change to the WLM peak is observed, indicating that the unhybridized line-defect mode is unaffected by surface binding. A slight reduction in the transmission levels is observed for the SLM resonance due to the increased frequency separation between the unhybridized surface and line-defect modes as a result of the redshift of the former.
For WBT analyte binding [ Fig. 7(b) ], we note that both the WLM and SLM transmission peaks are redshifted. The redshift increases with the uniform WBT analyte-layer thickness. In addition to this peak-shift behavior, the WBT binding configuration leads to enhancement of the SLM peak transmission level with a thickening of the analyte layers. This enhancement occurs because the central-waveguide blocks (with larger surface area) receive more analyte than the surface-grating blocks. Therefore, the unhybridized line-defect mode is redshifted more than the surface modes. This variable redshift reduces (ω almost degenerate (cf. Appendixes B and C for more details). For a significant redshift of one of the surface modes, the SLM transmission peak splits into two peaks, suppressing SLM transmission. The corresponding shift away from the line-defect-mode frequency results in fewer photons being able to tunnel through the chip by hopping from the entry surface, through the central line defect, to the exit surface. This result is manifest in the overall transmission suppression. Despite the similar behavior of the SLM transmission peaks, the WB-WT bindings are distinct from the B-T bindings. The former involve redshifts to the WLM resonance peak. Consequently, the frequency-overlap reduction between the unhybridized surface modes and the waveguide mode is less pronounced compared to the B-T binding. As a result, the SLM transmission suppression is less drastic for the WB-WT binding.
Key features of the transmission spectral fingerprints of Figs. 6 and 7 are shown in Fig. 8 . We track the WLM resonance frequencies, as well as SLM resonance frequencies and transmission levels, when two peaks are present in the spectrum. A least-squares fitting method, based on three Lorentzian functions, is employed to facilitate tracking of the split SLM peaks and their suppressed transmission levels at t=a ≥ 0.050 for B-T and WB-WT analyte bindings.
We note that the behavior of the WLM in our biosensor is very much akin to that of a traditional resonance-shift biosensor for all analyte-binding configurations involving the W site-i.e., for W, WB-WT, and WBT. It is only for these configurations that there is a redshift of the WLM peak [ Fig. 8(a) ]. We note here that the slopes of plots in Fig. 8(a) give the resonance-shift sensitivity values of the WLM. The peak WLM transmission remains at almost 100% for all analyte-binding configurations. Traditional resonance-shift biosensing is also demonstrated for the SLM in Fig. 8(b) , where the slopes of the plots represent the resonance-shift sensitivity of the LOC device. Plots in Fig. 8(c) track the SLM peak transmission levels as enhanced or suppressed by analyte binding, and their slopes quantify the peak transmission-level sensitivity for the analyte-binding configurations shown.
A summary of the detection capability of multiple disease markers by our biosensor is presented in Table I . There are six distinctive signatures in the transmission signal for the various analyte-binding configurations. In order to elucidate the six different cases detectable, we consider three different biological markers labeled α, β, and γ, which attach to the sites T, B, and W, respectively. Our biosensor distinguishes the following cases: For this section, we discuss both the l ¼ 3 and the l ¼ 4 LS chips. An important feature of our LS-chip biosensor for l ¼ 3 is that one of the SLM peaks does not shift due to W binding as seen in Fig. 9 . We note that the FDTD results in per unit of periodicity. Electric field snapshots for the SLMs and WLM in Fig. 9 are shown in Fig. 10 . As discussed in Appendix B, the SLM in Fig. 9 that is insensitive to W binding is an antisymmetric linear combination of the top and bottom surface modes. The waveguide line defect is centered at a nodal line of this mode, as seen from Fig. 10(b) . Consequently, this mode is insensitive to refractive-index changes near the waveguide. On the other hand, the other SLM-approximated by a symmetric linear combination of the upper and lower surface modesexhibits a notable response to W binding, having a notable presence of fields near this binding site [ Fig. 10(a) ].
Spurious signal changes due to environmental factors, such as temperature fluctuations, are common problems in a biosensor [24] . Temperature fluctuations change the analyte refractive index, disrupting the calibration of the device for measuring the analyte thickness. A referencing mechanism that provides a baseline to be established for measurements is valuable in this context. The antisymmetric SLM is useful for such referencing. As shown in Appendix B, the antisymmetric SLM has a frequency equal to that of the unhybridized surface mode. While insensitive to W binding, it is sensitive to the refractive index of the fluid medium. This discrimination provides a tool to monitor changes in ambient conditions, like temperature, that alter refractive-index values for the fluid and analyte.
For example, we consider an artificially enhanced analyte refractive index (n an > 1.45) due to temperature fluctuations, etc. A thinner layer of this higher-index analyte may cause a frequency shift equal to that of a thicker layer of regular-index analyte. In the absence of a referencing mechanism for the analyte refractive index, the sensor will be incorrectly calibrated, leading to an artificially amplified frequency shift and a subsequent overrepresentation of the analyte thickness. A more detailed discussion for n an variation is presented in Appendix D. The position of the antisymmetric SLM peak can be used to probe the ambient conditions due to its sensitivity to conditions of the fluid environment, thus establishing a benchmark for the analyte-thickness sensitivity based on the correct refractive index. For this calibration of the analyte refractive index to be useful, a compendium of the behavior of the sensor over a range of analyte and fluid-medium refractive indices has to be established. Typical results are shown in Appendix D.
For referencing, the l ¼ 3 LS chip can be used to supplement detections in the l ¼ 4 chip. Both the detector and the reference chips can receive the same sample by means of a "split-mesa" superchip that fabricates the two chips side by side [25] . The biorecognition occurs in the l ¼ 4 chip. Two spectral measurements are taken from the superchip: one for the reference and one for the detection.
D. Practical considerations
We have discounted considerations of light coupling into the glass superstrate-substrate regions from an air environment as may be expected to be the case for an experimental setup. This issue of light coupling needs to be addressed in detail for an operational sensor based on our prototype. TABLE I. Transmission spectrum response to the increase of analyte-layer thickness for the various analyte-binding configurations. The frequency shifts of the WLM and the frequency shifts, transmission levels, and peak-splitting characteristics of the two SLMs provide the means for differentiating between various analyte-binding configurations. The results presented here are, primarily, conceptual in nature. However, our conceptual prototype may be conveniently extended to involve the guided modes of a more readily fabricated, and structurally stable, PC shown in Fig. 2(c) . This 3D woodpile architecture consists of alternating layers of planar gratings lying orthogonally to each other. Our 2D geometry is structurally similar to a section through the 3D simple-cubic woodpile depicted [ Fig. 2(c) ]. Our squares correspond to logs of the simplecubic woodpile oriented only along a certain direction. In order to achieve a complete 3D PBG, it is necessary to replace the simple-cubic woodpile with a face-centered cubic (diamond-structure) woodpile [26] . The fabrication of such 3D woodpiles, along with engineering of defects thereof, is well documented [27, 28] .
V. CONCLUSION
We present the conceptual prototype of a LOC optical biosensor based on a finite-sized PBG material embedded in a glass slide and interspersed with microfluidic channels. A sensing mechanism based on weak coupling of the PBG surface and line-defect waveguide modes is numerically demonstrated. FDTD calculations are used to establish that a conventional resonance peak-shift approach can be supplemented by transmission suppression or enhancement effects in order to facilitate the detection of variable amounts of thin-layer analytes. Unlike previous biosensors that rely exclusively on analyte-induced changes to a single optical resonance mode, our detection scheme includes the effects of analyte-induced changes to the coupling between nearby optical resonances in frequency space. This scheme leads to more detailed spectral fingerprints of samples containing a mixture of various disease markers. The mode volumes of our optical resonances cover a large volume fraction of the entire LOC. In the mousetrap analogy, this coverage enables the mice (disease markers) to readily find their traps (binding sites), which reduces the required sample volume and time required for detection to occur.
Most significantly, we demonstrate that our sensing strategies enable the quantitative detection of six different combinations of up to three separate biological markers. This result offers a valuable mechanism for the diagnosis of diseases characterized by the presence of multiple biological factors in a diagnostic sample.
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APPENDIX A: OPERATIONAL DEFINITIONS OF SENSITIVITY AND LIMIT OF DETECTION FOR RESONANCE-SHIFT BIOSENSING
The resonance-shift sensitivity for the mth mode of our biosensor is defined as the rate of change of resonance frequency, ω m , with analyte-layer thickness t:
An estimate [29] of this sensitivity is found by using the first-order perturbation theory on the Maxwell wave equation. The shift δω m in resonance frequency for "small" increments δt to the analyte-layer thickness is approximated [by using the electric field pattern E m ðrÞ and the dielectric constants of the analyte, ε A , and the fluid, ε F ] as a a ratio of two integrals-one over the "area" of the fluidanalyte interface regions, I, and the other over the entire supercell volume S of the PC:
The optical field concentration of the mth mode at the analyte-binding interface, F m , is given by [29] F m ≡ − 1 2
Here, E m;jj ðrÞ is the component of the electric field directed tangentially along the interface I, while E m;⊥ ðrÞ is the component normal to the interface. For a D-dimensional system, integration in the numerator is in (D − 1) dimensions, whereas the integral in the denominator is in D dimensions (D ¼ 2 for our system). Clearly, the resonanceshift sensitivity is as shown in Eq. (2):
The sensitivity is proportional to the optical field concentration at the fluid-analyte interface. The higher the proportion of the mode energy that is concentrated at the interface I, the larger the frequency shift in response to the analyte binding. 
Using the relationship between the sensitivity and the optical field concentration, F m , as well as the definition of the quality factor, Q m ¼ ω m =Δω m , we arrive at Eq. (3):
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APPENDIX B: SIMPLIFIED MODE-COUPLING MODEL OF THE PHOTONIC-BAND-GAP RESONANCES
We consider an operator form of the Maxwell wave equation (1) written as (setting c ¼ 1 for convenience)
1. Degeneracy lifting of surface modes in the l ¼ 3 S chip
We consider a PC chip with two degenerate surface modes js 1 i and js 2 i at the Γ point (k ¼ 0)-corresponding to the top and the bottom surface modes of the chip-with an eigenfrequency ω S . In a small neighborhood of frequency space centered around ω ¼ ω S , the operator in the PC wave equation can be approximated for the case of noninteracting degenerate surface modes as
Here, we use the fact that the PBG has removed all other modes in this frequency range within the chip. By introducing a weak coupling κ (with dimensions of frequency squared), between js 1 i and js 2 i, the Maxwell operator becomes
The foregoing is a 2 × 2 matrix in the fjs 1 i; js 2 ig basis:
This matrix has eigenvalues:
These eigenvalues are associated with the antisymmetric and symmetric linear combinations of the original surface modes.
Hybridization of surface and line-defect modes in the l ¼ 4 LS chip
For a thicker l ¼ 4 chip, we assume no direct coupling between the surface modes js 1 i and js 2 i. They remain degenerate with frequency ω S . A central line-defect mode jli is introduced with frequency ω L . We choose ω L > ω S . In the absence of coupling between the modes, the Maxwell operator in Eq. (B1) is
As before, we assume that the PBG excludes all other modes with nearby frequencies in the chip. We now introduce a weak evanescent coupling between the surface and line-defect modes but assume negligible coupling between the two surface modes. The Maxwell operator becomes
By symmetry, the coupling strength between the upper surface mode and the central line-defect mode is the same as the coupling strength between the lower surface mode and the central line-defect mode. In other words,
In the fjs 1 i; js 2 i; jlig basis, the operator is a 3 × 3 matrix:
Its eigenvalues ξ satisfy the cubic equation (B9):
The solutions to Eq. (B9) are ξ ¼ ω
In the weak coupling limit defined by the condition jκj ≪ ðω
These correspond to three resonance peaks in the optical transmission through the LS chip, as seen for l ¼ 3 in Fig. 9 , whereas the jκj → 0 limit is reached for l > 3 in Figs. 11(a) and 11(b) (cf. Appendix C). As a result of the off-diagonal interaction terms in our matrix, perturbed frequencies (squared) have corrections analogous to second-order perturbations in quantum-mechanical systems [23] .
a. Antisymmetric surfacelike mode at ξ ¼ ω
S
The eigenvector of M 1 corresponding to the eigenvalue ξ ¼ ω 2 S is an antisymmetric linear combination of the surface modes given by ½þ2 −1=2 ; −2 −1=2 ; 0 T (whether or not the limit jκj → 0 applies). There is no influence of the line-defect modes at all for this SLM.
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In the limit jκj → 0, the mode frequency ξ ≈ ω
becomes degenerate with the antisymmetric SLM, but with eigenvector ½þ2 −1=2 ; þ2 −1=2 ; 0 T . Therefore, this SLM is a symmetric linear combination of the surface modes. For the case of non-negligible κ, this SLM corresponds to the lowest frequency in the transmission spectrum (as seen for the l ¼ 3 case of the LS chip in Fig. 9 ). This SLM involves slight mixing of the central line-defect mode.
, with an eigenvector ½0; 0; 1 T . As a result, the eigenstate is essentially a line-defect mode. When the limit jκj → 0 is not strictly satisfied, this eigenstate may be called a WLM with some weak mixing with the surface modes.
In the situation where ω L ≈ ω S , the exact solution of the cubic eigenvalue equation (B9) must be considered. While the antisymmetric SLM at ξ ¼ ω 2 S is retained with its previous interpretation, the other eigenvalues become
. These eigenvalues are both based on a symmetric combination of surface modes, with the central waveguide and surface-mode amplitudes having either the same sign or the opposite sign. The central waveguide field intensity is roughly twice that of either surface region. This result leads to a distinctive three-peak signature in the transmission structure as discussed in Appendix D.
APPENDIX C: THE EFFECTS OF CHIP THICKNESS AND FABRICATION PRECISION

Optimal chip thickness
Here, we address the question of optimum thickness of our LOC biosensor. If the chip thickness is too small (l ≤ 3), the Q factor of the transmission resonances becomes small, and the resonance-shift limit of detection becomes poor. On the other hand, when the chip is too thick (l ≥ 5), the transmission resonances become very narrow and are easily dominated by disorder from fabrication imperfections.
We concentrate here on the LS chip shown in Fig. 2(a) , with l ∈ f3; 4; 5g. All the FDTD calculations here are undertaken with a spatial resolution of 40 mesh points per unit of lattice periodicity a. The FDTD spatial resolution is representative of the fabrication precision; i.e., the device may have imperfections of up to the order of the FDTD mesh-step size. For illustration, we consider only W binding.
Calculated transmission spectra for the three chip thicknesses are presented in Figs. 9 and 11. For the l ¼ 3 chip in Fig. 9 , the original surface and waveguide modes, in the absence of analyte binding, are well coupled due to their spatial proximity. The presence of a nonnegligible coupling between the two surface modes is manifest in the dual-peak signature of the SLMs in the transmission spectrum (cf. Appendix B for details). Moreover, there is a pronounced frequency separation between the transmission peaks for the SLMs and the WLM. SLM transmission enhancement with analyte binding-observed for the l ¼ 4 and l ¼ 5 LS chips-is not observed.
As discussed in Appendix B, the SLMs can be considered as symmetric and antisymmetric linear combinations of the unhybridized surface modes. On the other hand, the WLM consists mostly of optical fields concentrated near the waveguide line-defect region of the LS chip. Electric field snapshots for the l ¼ 3 chip, presented in Fig. 10 , lend support to the mode characteristics expected from a linear combination of surface and line-defect modes. As discussed in Appendix B, the lower-frequency SLM is roughly a symmetric linear combination of the surface modes. The field map in Fig. 10(a) at frequency ðωaÞ=ð2πcÞ ¼ 0.2791 confirms this interpretation, revealing a distinct nonzero optical field concentration equidistant from the two surfaces (near the line-defect region) as well as a symmetric field distribution above and below the line defect. The fields in Fig. 10(b) The symmetric SLM for l ¼ 3 is sensitive to analyte binding at the W site, whereas the antisymmetric SLM is not [Figs. 9, 10(a), and 10(b)]. In the case of l > 3, the symmetric and antisymmetric SLM transmission peaks are no longer distinguishable. The overall transmission enhancement of the SLMs for l > 3 from W binding is due to the waveguide-mediated surface-mode coupling, as explained earlier.
As seen from Figs. 10(a) and 10(b), the symmetric SLM has lower frequency than the antisymmetric one and is sensitive to W binding. For an analyte having a higher refractive index than the background fluid, the symmetric SLM undergoes a redshift (by the first-order perturbation theory [29] ). This redshift moves the symmetric SLM transmission peak even lower in frequency relative to the antisymmetric SLM. This response to W binding is evident in the spectra for the l ¼ 3 chip (Fig. 9) .
The l ¼ 3 chip exhibits direct surface-surface coupling. This coupling is indicated by the fact that, for each of the SLM and WLM peaks, the peak transmission remains almost 100%. A larger value for l is desirable to operate in the highly responsive weak-coupling regime between guided modes. In this regime, the SLM frequencies are nearly degenerate.
Inspection of Figs. 11(a) and 11(b) reveals that the l ¼ 4 chip provides the optimal chip thickness for multiparametric biosensing. It exhibits a single SLM peak for W binding that can split into two peaks with B-T binding as well as WB-WT binding. There is also a reasonable free spectral range between the SLM and WLM peaks, allowing for frequency-shift biosensing using the WLM. Moreover, the frequency separation of the WLM and the SLMs is ideal for transmission changes to occur significantly with analyte-thickness changes (Fig. 12) . For the l ¼ 5 chip, the coupling between modes becomes too weak, the overall transmission intensities drop significantly, and the spectral response of the biosensor deteriorates considerably with fabrication-induced disorder.
Comparison of W binding in the l ¼ 4 LS chip for different fabrication precisions
We now compare the performance of the l ¼ 4 LS chip for resolutions of 40 and 80 mesh steps per lattice period. This comparison is an indicator of its performance for different degrees of precision in fabrication. From comparisons of spectral data, it is found that the resonance-shift sensitivities of the WLM and the SLMs for the W-binding configuration are comparable for both resolutions, with the higher-resolution results being marginally better. We conclude that the resolution does not have a very significant effect on the resonance-shift sensitivity. However, Q factors are lower for modes calculated with lower resolution. For example, in the WLM with no analyte binding (t=a ¼ 0), Q ≈ 3500 at a resolution of 80 mesh steps per unit of periodicity, while for the same value of the analyte thickness, Q ≲ 3000 at a resolution of 40 mesh steps per unit of periodicity. It is well known that a lower precision of fabrication compromises the Q factors of resonant modes.
Comparing the high-and low-resolution results for the W-binding case of l ¼ 4 [ Figs. 6 and 11(a) , respectively], it is seen that the position of the low-Q SLM peak for t=a ¼ 0 is essentially oblivious to resolution, but the high-Q WLM peak occurs at a lower frequency for the lower-precision FDTD results. The coarser subpixel averaging of the lowresolution case leads to a larger overall index for the waveguide region, leading to a lower frequency for the WLM. Such resolution-dependent changes to the position of high-Q resonances are a known FDTD issue. FIG. 12 . Peak transmission vs analyte thickness in W binding for various LS-chip thicknesses. The most conspicuous changes to the transmission levels are observed for the l ¼ 4 case, which constitutes the best choice for the coupling level between the surface and line-defect modes of the biosensor device. In other words, the choice of optimal chip thickness is dictated largely by optimal peak transmission-level sensitivity.
Nonetheless, the interaction of the WLM and SLM leading to SLM peak transmission enhancements is observed for both resolutions. Therefore, it is still possible to obtain a detailed spectral fingerprint under different fabrication precisions for the device.
We also note that our proposed biosensor is capable of detecting analyte-thickness changes that are of the same order as the fabrication accuracy of the PC chip. For a spatial resolution of 40 mesh points per lattice period, a (mesh size of Δ ¼ a=40), our system distinguishes changes to analyte-layer thickness of δt ¼ Δ, i.e., δt=a ¼ 0.025. Our device nevertheless still needs to conform to a high degree of fabrication fineness. For example, if δw sg =a ¼ 0.05 instead of δw sg =a ¼ 0.10 and δw wg =a ¼ 0.05 instead of δw wg =a ¼ 0.10, the transmission for the frequency window considered is uniformly zero.
APPENDIX D: VARIATION OF ANALYTE REFRACTIVE INDEX
Here, we present some details due to the variation of the analyte refractive index n an . The FDTD results discussed are based on a spatial resolution of 40 mesh points per unit of periodicity, with 1.35 ≤ n an ≤ 1.55 and t=a ¼ 0.01. Figure 13 depicts transmission spectra for the BT, W, and WB-WT analyte-binding cases. In Fig. 13(a) , for the BT-binding case, the SLMs are seen to redshift with progressive enhancement of n an . The W and WB-WT cases depicted in Figs. 13(b) and 13(c) , respectively, present some intricacies, particularly for the case of n an ¼ 1.50. For the spectral signature for the W case in Fig. 13(b) , instead of the usual two-peak signature seen for other n an values, there is an anomalous three-peak signature at n an ¼ 1.50. Analyte binding redshifts the intrinsic line-defect-mode frequency ω L , bringing it very close to the intrinsic surfacemode frequency ω S , causing ω L ≈ ω S . As discussed in Appendix B, while the central peak is still due to the antisymmetric SLM, the two peripheral peaks are due to two strongly hybridized modes and involve the symmetric combination of the surface modes which are in phase or out of phase with the line-defect mode. In the case of the WB-WT binding in Fig. 13(c) , the three-peak transmission scenario for the larger values of n an is due to SLM peak splitting, observed earlier, as well as due to the ω L ≈ ω S situation around n an ¼ 1.50. Similar effects of ω L ≈ ω S will occur for certain combinations of n an and t and must be accounted for during the calibration and operation of the sensor. 
